50
Participants
Start Date
January 1, 2019
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
TNF-inhibition
Initiation of immunosuppression with any TNF-inhibitor, e.g. infliximab, etanercept or adalimumab
RECRUITING
Reumatologi SUS Lund, Region Skåne, Lund
Region Skane
OTHER